In a pregnant patient in the second trimester with an elevated middle cerebral artery (MCA) Doppler peak systolic velocity (PSV) ≥1.5 multiples of the median (MoM) indicating moderate‑to‑severe fetal anemia, what is the recommended diagnostic confirmation and treatment plan?

Management of Elevated MCA-PSV ≥1.5 MoM in Second Trimester

When MCA-PSV reaches ≥1.5 MoM in the second trimester, immediately refer the patient to a tertiary center with expertise in invasive fetal therapy for fetal blood sampling (cordocentesis) with preparation for intrauterine transfusion. 1

Diagnostic Confirmation

Fetal blood sampling (cordocentesis) is the definitive diagnostic test and must be performed when MCA-PSV exceeds 1.5 MoM to confirm the presence and severity of anemia before any therapeutic intervention. 1

Key Points About MCA-PSV Screening:

• Sensitivity approaches 100% (95% CI 0.86-1.00) for detecting moderate-to-severe fetal anemia, making it highly reliable for ruling in disease. 2, 3
• False-positive rate is approximately 12% with a single measurement, meaning roughly 1 in 10 fetuses with elevated MCA-PSV will not actually be severely anemic—this is why confirmatory cordocentesis is mandatory before transfusion. 1, 2, 3
• Serial measurements reduce the false-positive rate to <5%, improving specificity when trend analysis shows progressively rising values. 2

Laboratory Evaluation at Cordocentesis:

• Complete blood count with hemoglobin and hematocrit to quantify anemia severity. 2
• Fetal blood typing to guide transfusion planning. 2
• TORCH serologies (toxoplasmosis, rubella, CMV, HSV, HIV, syphilis) to identify infectious etiologies of anemia. 2

Anemia Severity Classification

Fetal anemia severity is categorized by hemoglobin concentration expressed as multiples of the median (MoM) for gestational age: 1

• Mild anemia: MoM 0.83–0.65
• Moderate anemia: MoM 0.64–0.55
• Severe anemia: MoM <0.55

Alternatively, fetal hematocrit <30% is equally reliable as a cutoff for diagnosing fetal anemia and is commonly used in clinical practice. 1

Treatment Plan

Intrauterine Transfusion (IUT):

Perform IUT when cordocentesis confirms moderate-to-severe anemia, unless gestational age is ≥34–35 weeks, at which point delivery may be safer than the procedural risks of transfusion. 1, 2

• Transfusion volume calculation uses standardized formulas that account for donor unit hematocrit, estimated fetal weight, and target final fetal hematocrit. 1
• Referral to a specialized center is essential because IUT requires a coordinated team experienced in fetal blood sampling and transfusion techniques. 1

Timing of Subsequent Transfusions:

• MCA-PSV can guide timing of the second and subsequent transfusions, with the same threshold of ≥1.5 MoM indicating recurrent anemia. 1, 4
• The correlation between MCA-PSV and fetal hemoglobin remains accurate even after two previous transfusions, so Doppler surveillance continues to be reliable throughout serial IUT procedures. 4
• Some evidence suggests raising the cutoff to ≥1.74 MoM after the first IUT may reduce unnecessary procedures (specificity 90% vs. 50%) without significantly compromising sensitivity (75% vs. 83.3%). 5

Surveillance Protocol

Frequency of MCA-PSV Monitoring:

• Begin surveillance at 18–20 weeks gestation, when fetal blood sampling and IUT become technically feasible. 1
• After 24 weeks, perform weekly MCA-PSV measurements in at-risk pregnancies, with more frequent monitoring if MCA-PSV values are rising or other ultrasound findings suggest worsening anemia. 1, 2

Proper MCA-PSV Measurement Technique:

To avoid false-positive results, strict adherence to standardized technique is critical: 1, 2

1. Obtain an axial view of the fetal head at the level of the sphenoid bones during fetal quiescence (no breathing or movements).
2. Visualize the circle of Willis with color Doppler and zoom so the MCA occupies >50% of the image.
3. Sample the proximal MCA approximately 2 mm distal to its origin from the internal carotid artery.
4. Align the ultrasound beam as close to 0° as possible, parallel to the artery along its entire length.
5. Avoid angle correction, which leads to overestimation of velocity and false-positive results. 2
6. Perform at least three consecutive measurements and record the highest MCA-PSV value for clinical decision-making.
7. Procedure time is 5–10 minutes when performed by a trained operator. 1, 2

Common Pitfalls to Avoid

• Measuring too distal in the MCA or applying angle correction produces falsely elevated values and should be avoided. 2
• Acquiring Doppler traces during fetal movement causes heart-rate-related velocity variability that compromises accuracy. 1, 2
• Inexperienced operators may produce misleading results; patients at risk for anemia should be referred to centers with certified sonographers. 2
• Do not use amniotic fluid delta OD450 for diagnosing fetal anemia—MCA-PSV has replaced this outdated method. 1

Delivery Planning

Plan delivery at 37–38 weeks gestation for pregnancies with a fetus at risk for anemia, unless maternal or fetal complications necessitate earlier intervention. 1, 2

Applicability Across Etiologies

MCA-PSV is universally applicable for detecting fetal anemia regardless of underlying cause, including: 1, 2

• Red cell alloimmunization (Rh disease)
• Parvovirus B19 infection
• Twin-twin transfusion syndrome (donor twin)
• Fetomaternal hemorrhage
• Alpha-thalassemia and other inherited hemoglobinopathies